Vivid Capex To Depreciation vs Days Sales Outstanding Analysis

SEAT Stock

USD 7.00 0.21 2.91%

Vivid Seats financial indicator trend analysis is much more than just breaking down Vivid Seats prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vivid Seats is a good investment. Please check the relationship between Vivid Seats Capex To Depreciation and its Days Sales Outstanding accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivid Seats. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Vivid Stock please use our How to Invest in Vivid Seats guide.

Capex To Depreciation vs Days Sales Outstanding

Capex To Depreciation vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vivid Seats Capex To Depreciation account and Days Sales Outstanding. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Vivid Seats' Capex To Depreciation and Days Sales Outstanding is -0.05. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of Vivid Seats, assuming nothing else is changed. The correlation between historical values of Vivid Seats' Capex To Depreciation and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Vivid Seats are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Capex To Depreciation i.e., Vivid Seats' Capex To Depreciation and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

-0.05

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Days Sales Outstanding

Most indicators from Vivid Seats' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vivid Seats current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vivid Seats. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy Vivid Stock please use our How to Invest in Vivid Seats guide.At this time, Vivid Seats' Tax Provision is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 0.51 in 2026, whereas Selling General Administrative is likely to drop slightly above 134.8 M in 2026.

	2023	2024	2025	2026 (projected)
Interest Expense	13.5M	23.2M	20.9M	27.6M
Depreciation And Amortization	18.0M	45.9M	41.3M	29.0M

Interest Expense Depreciation And Amortization

Vivid Seats fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab
Total Assets		-0.35	-0.11	0.13	0.49	0.14	0.31	0.45	0.12	-0.1	0.18	0.48	-0.14	0.77	0.49	0.45	-0.32	-0.14	0.35	0.69	0.07	-0.14	0.7	-0.38	0.66	-0.19
Short Long Term Debt Total	-0.35		-0.43	-0.51	0.01	-0.49	-0.83	-0.85	-0.78	0.66	0.37	-0.76	-0.08	-0.17	-0.8	-0.92	0.93	-0.08	-0.67	-0.04	-0.39	0.83	-0.81	0.17	-0.52	0.73
Other Current Liab	-0.11	-0.43		0.72	-0.42	0.4	0.59	0.66	0.64	-0.48	-0.81	0.56	0.48	-0.43	0.51	0.56	-0.38	0.48	0.79	-0.55	0.29	-0.34	0.49	0.65	0.49	0.14
Total Current Liabilities	0.13	-0.51	0.72		-0.7	0.91	0.29	0.7	0.92	-0.9	-0.94	0.89	0.83	-0.48	0.51	0.55	-0.69	0.83	0.92	-0.6	0.56	-0.72	0.67	0.71	0.2	-0.12
Total Stockholder Equity	0.49	0.01	-0.42	-0.7		-0.75	0.28	-0.08	-0.59	0.69	0.81	-0.38	-0.88	0.9	0.09	0.07	0.28	-0.88	-0.4	0.93	-0.38	0.47	0.0	-0.84	0.46	-0.06
Other Liab	0.14	-0.49	0.4	0.91	-0.75		0.08	0.56	0.88	-0.97	-0.81	0.84	0.85	-0.45	0.41	0.43	-0.75	0.85	0.73	-0.55	0.51	-0.83	0.58	0.55	-0.05	-0.33
Net Tangible Assets	0.31	-0.83	0.59	0.29	0.28	0.08		0.82	0.49	-0.28	-0.24	0.51	-0.17	0.28	0.82	0.9	-0.61	-0.17	0.57	0.16	0.11	-0.44	0.68	-0.2	0.78	-0.43
Property Plant And Equipment Net	0.45	-0.85	0.66	0.7	-0.08	0.56	0.82		0.78	-0.68	-0.58	0.83	0.34	0.06	0.96	0.97	-0.81	0.34	0.83	-0.07	0.24	-0.71	0.85	0.13	0.65	-0.48
Current Deferred Revenue	0.12	-0.78	0.64	0.92	-0.59	0.88	0.49	0.78		-0.95	-0.83	0.92	0.64	-0.35	0.62	0.71	-0.91	0.64	0.88	-0.49	0.61	-0.91	0.74	0.44	0.22	-0.45
Net Debt	-0.1	0.66	-0.48	-0.9	0.69	-0.97	-0.28	-0.68	-0.95		0.81	-0.87	-0.77	0.44	-0.55	-0.59	0.86	-0.77	-0.76	0.54	-0.49	0.93	-0.63	-0.46	-0.03	0.48
Retained Earnings	0.18	0.37	-0.81	-0.94	0.81	-0.81	-0.24	-0.58	-0.83	0.81		-0.71	-0.86	0.71	-0.4	-0.42	0.54	-0.86	-0.81	0.81	-0.45	0.6	-0.44	-0.85	-0.07	-0.01
Accounts Payable	0.48	-0.76	0.56	0.89	-0.38	0.84	0.51	0.83	0.92	-0.87	-0.71		0.56	-0.06	0.69	0.75	-0.87	0.56	0.93	-0.21	0.58	-0.8	0.92	0.33	0.47	-0.35
Cash	-0.14	-0.08	0.48	0.83	-0.88	0.85	-0.17	0.34	0.64	-0.77	-0.86	0.56		-0.73	0.22	0.14	-0.36	1.0	0.56	-0.78	0.22	-0.51	0.23	0.84	-0.22	0.03
Non Current Assets Total	0.77	-0.17	-0.43	-0.48	0.9	-0.45	0.28	0.06	-0.35	0.44	0.71	-0.06	-0.73		0.18	0.19	0.03	-0.73	-0.17	0.98	-0.13	0.23	0.3	-0.83	0.56	-0.18
Non Currrent Assets Other	0.49	-0.8	0.51	0.51	0.09	0.41	0.82	0.96	0.62	-0.55	-0.4	0.69	0.22	0.18		0.96	-0.73	0.22	0.65	0.07	-0.02	-0.64	0.76	-0.05	0.65	-0.56
Other Assets	0.45	-0.92	0.56	0.55	0.07	0.43	0.9	0.97	0.71	-0.59	-0.42	0.75	0.14	0.19	0.96		-0.83	0.14	0.72	0.07	0.22	-0.72	0.83	-0.08	0.66	-0.61
Long Term Debt	-0.32	0.93	-0.38	-0.69	0.28	-0.75	-0.61	-0.81	-0.91	0.86	0.54	-0.87	-0.36	0.03	-0.73	-0.83		-0.36	-0.72	0.15	-0.51	0.96	-0.8	-0.03	-0.29	0.74
Cash And Short Term Investments	-0.14	-0.08	0.48	0.83	-0.88	0.85	-0.17	0.34	0.64	-0.77	-0.86	0.56	1.0	-0.73	0.22	0.14	-0.36		0.56	-0.78	0.22	-0.51	0.23	0.84	-0.22	0.03
Net Receivables	0.35	-0.67	0.79	0.92	-0.4	0.73	0.57	0.83	0.88	-0.76	-0.81	0.93	0.56	-0.17	0.65	0.72	-0.72	0.56		-0.33	0.6	-0.64	0.86	0.5	0.55	-0.11
Good Will	0.69	-0.04	-0.55	-0.6	0.93	-0.55	0.16	-0.07	-0.49	0.54	0.81	-0.21	-0.78	0.98	0.07	0.07	0.15	-0.78	-0.33		-0.24	0.32	0.14	-0.87	0.43	-0.16
Common Stock Shares Outstanding	0.07	-0.39	0.29	0.56	-0.38	0.51	0.11	0.24	0.61	-0.49	-0.45	0.58	0.22	-0.13	-0.02	0.22	-0.51	0.22	0.6	-0.24		-0.45	0.49	0.3	0.04	-0.05
Non Current Liabilities Total	-0.14	0.83	-0.34	-0.72	0.47	-0.83	-0.44	-0.71	-0.91	0.93	0.6	-0.8	-0.51	0.23	-0.64	-0.72	0.96	-0.51	-0.64	0.32	-0.45		-0.64	-0.14	-0.06	0.76
Inventory	0.7	-0.81	0.49	0.67	0.0	0.58	0.68	0.85	0.74	-0.63	-0.44	0.92	0.23	0.3	0.76	0.83	-0.8	0.23	0.86	0.14	0.49	-0.64		0.03	0.73	-0.35
Other Current Assets	-0.38	0.17	0.65	0.71	-0.84	0.55	-0.2	0.13	0.44	-0.46	-0.85	0.33	0.84	-0.83	-0.05	-0.08	-0.03	0.84	0.5	-0.87	0.3	-0.14	0.03		-0.18	0.47
Other Stockholder Equity	0.66	-0.52	0.49	0.2	0.46	-0.05	0.78	0.65	0.22	-0.03	-0.07	0.47	-0.22	0.56	0.65	0.66	-0.29	-0.22	0.55	0.43	0.04	-0.06	0.73	-0.18		0.0
Total Liab	-0.19	0.73	0.14	-0.12	-0.06	-0.33	-0.43	-0.48	-0.45	0.48	-0.01	-0.35	0.03	-0.18	-0.56	-0.61	0.74	0.03	-0.11	-0.16	-0.05	0.76	-0.35	0.47	0.0

Click cells to compare fundamentals

Vivid Seats Account Relationship Matchups

Vivid Seats fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	1.4B	1.2B	1.6B	1.6B	1.9B	1.5B
Short Long Term Debt Total	702.8M	282.6M	284.8M	407.6M	366.9M	422.3M
Other Current Liab	38.5M	181.4M	191.6M	165.0M	189.8M	158.7M
Total Current Liabilities	497.5M	378.0M	487.8M	425.8M	489.7M	418.7M
Total Stockholder Equity	(860.7M)	(382.7M)	105.0M	261.1M	300.3M	315.3M
Property Plant And Equipment Net	1.1M	18.3M	20.0M	24.6M	28.3M	29.7M
Current Deferred Revenue	25.1M	32.0M	34.7M	23.8M	27.4M	23.4M
Net Debt	(29.4M)	31.0M	152.3M	164.2M	147.7M	192.2M
Retained Earnings	(1.0B)	(1.0B)	(945.7M)	(930.2M)	(837.2M)	(879.0M)
Accounts Payable	191.2M	161.3M	257.5M	233.0M	267.9M	182.8M
Cash	489.5M	251.5M	132.4M	243.5M	280.0M	272.0M
Non Current Assets Total	798.6M	819.9M	1.3B	1.3B	1.5B	1.2B
Non Currrent Assets Other	787K	4.4M	3.1M	5.2M	6.0M	6.3M
Long Term Debt	460.1M	264.9M	264.6M	385.0M	346.5M	380.3M
Cash And Short Term Investments	489.5M	251.5M	132.4M	243.5M	280.0M	272.0M
Net Receivables	36.1M	36.5M	58.5M	48.3M	55.6M	43.9M
Good Will	718.2M	715.3M	947.4M	943.1M	1.1B	929.1M
Common Stock Shares Outstanding	77.5M	9.9M	198.9M	10.5M	12.0M	11.4M
Liabilities And Stockholders Equity	1.4B	1.2B	1.6B	1.6B	1.9B	1.5B
Non Current Liabilities Total	486.0M	293.3M	475.6M	596.3M	536.6M	502.2M
Inventory	11.8M	12.8M	21.0M	19.6M	22.5M	15.4M
Other Current Assets	62.9M	30.7M	34.1M	33.8M	30.4M	33.8M
Other Stockholder Equity	182.1M	631.4M	1.0B	1.2B	1.4B	840.4M
Total Liab	983.5M	671.3M	963.3M	1.0B	919.9M	806.6M
Net Invested Capital	(400.6M)	(115.1M)	373.6M	650.0M	585.0M	299.2M
Total Current Assets	610.2M	331.5M	246.0M	345.2M	396.9M	379.7M
Non Current Liabilities Other	25.8M	13.4M	29.0M	36.9M	42.4M	44.5M
Net Working Capital	112.7M	(46.5M)	(241.8M)	(80.6M)	(72.6M)	(68.9M)
Short Term Debt	242.6M	2.8M	3.9M	4.0M	3.6M	3.4M
Intangible Assets	78.5M	82.0M	241.2M	233.1M	268.1M	183.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Vivid Stock Analysis

When running Vivid Seats' price analysis, check to measure Vivid Seats' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vivid Seats is operating at the current time. Most of Vivid Seats' value examination focuses on studying past and present price action to predict the probability of Vivid Seats' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vivid Seats' price. Additionally, you may evaluate how the addition of Vivid Seats to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC